InsiderTrades

Form 4 for TXN Texas Instruments

Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-21 · accession 0001127602-25-006655 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-02-25 2025-02-21+ TXN TEMPLETON RICHARD K COB, Dir S - Sale+OE $202.70 -194.0K 472.8K -29% -$39.32M
DM 2025-02-25 2025-02-21+ TXN TEMPLETON RICHARD K COB, Dir M - OptEx $52.93 +194.0K 506.1K +62% +$10.27M
DM 2025-02-25 2025-02-21+ TXN TEMPLETON RICHARD K COB, Dir M - OptEx $0.00 -194.0K 295.6K -40% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-24 S D 24,116 $204.05 418,866 D — — (F8) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $203.525 to $204.52. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price
2 Common Common Stock 2025-02-24 S D 9,777 $204.86 409,089 D — — (F9) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $204.525 to $205.325. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price
3 Common Common Stock 2025-02-24 S D 18,943 $203.14 442,982 D — — (F7) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $202.52 to $203.515. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price
4 Common Common Stock 2025-02-24 S D 10,854 $201.85 461,925 D — — (F6) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $201.51 to $202.505. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price
5 Common Common Stock 2025-02-21 M A 97,000 $52.93 506,089 D — —
6 Common Common Stock 2025-02-21 S D 48,084 $201.96 458,005 D — — (F1) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $201.31 to $202.305. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
7 Common Common Stock 2025-02-21 S D 22,115 $202.75 435,890 D — — (F2) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $202.31 to $203.26. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
8 Common Common Stock 2025-02-21 S D 18,925 $203.84 416,965 D — — (F3) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $203.31 to $204.245. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
9 Common Common Stock 2025-02-21 S D 7,876 $204.56 409,089 D — — (F4) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $204.31 to $204.93. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
10 Common Common Stock 2025-02-24 M A 97,000 $52.93 506,089 D — —
11 Common Common Stock 2025-02-24 S D 33,310 $201.06 472,779 D — — (F5) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $200.51 to $201.505. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
12 Derivative NQ Stock Option (Right to Buy) 2025-02-21 M D 97,000 $0.00 392,557 D $52.93 · — to 2026-01-29 97,000 Common Stock (F13) The option became exercisable in four equal annual installments beginning on January 29, 2017.
13 Derivative NQ Stock Option (Right to Buy) 2025-02-24 M D 97,000 $0.00 295,557 D $52.93 · — to 2026-01-29 97,000 Common Stock (F13) The option became exercisable in four equal annual installments beginning on January 29, 2017.